EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON

Objective. The aim was to perform an indirect comparisons of the effectiveness and safety of new oral anticoagulants (NOACs) in the management of venous thromboembolism (VTE).Material and methods. In the absence of a head-to-head comparisons, indirect comparison was done using the method proposed by...

Full description

Bibliographic Details
Main Authors:	V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2016-12-01
Series:	Фармакоэкономика
Subjects:	indirect comparison new oral anticoagulants venous thromboembolism rivaroxaban apixaban dabigatran
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/152

Similar Items

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
by: Martina Mookadam, et al.
Published: (2015-01-01)

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

Direct oral anticoagulants and travel-related venous thromboembolism
by: Chamnanchanunt Supat, et al.
Published: (2018-11-01)

HOW NEW APPROACHES TO THE TREATMENT OF PULMONARY EMBOLISM AFFECT THE OUTCOME OF THE DISEASE?
by: M. Y. Gilyarov, et al.
Published: (2017-12-01)

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
by: Pamela L. Lutsey, et al.
Published: (2019-10-01)

Assessment and predictors of inappropriate dose of direct oral anticoagulants
by: Mosaad O. Almegren
Published: (2024-01-01)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
by: Maha Al-Ghafry, et al.
Published: (2022-10-01)

Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia
by: Evelien Krumb, et al.
Published: (2021-02-01)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
by: Danielle Groat, et al.
Published: (2022-05-01)

DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT
by: D. А. Napalkov, et al.
Published: (2017-03-01)

Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2016-03-01)

Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2017-01-01)

Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2017-01-01)

Prevention of recurrent deep-vein thrombosis
by: Andrew N Nicolaides
Published: (2019-01-01)

Are outpatient anticoagulation management services the wave of the future (again)?
by: Bethany Samuelson Bannow
Published: (2022-05-01)

Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
by: Ramin Artang, et al.
Published: (2019-07-01)

Direct oral anticoagulants; a review for the non-specialist
by: Thilina Gunawardena
Published: (2021-11-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

Novos anticoagulantes orais no tromboembolismo venoso e fibrilhação auricular New oral anticoagulants in the treatment of venous thromboembolism and atrial fibrillation
by: Luís Silvestre, et al.
Published: (2012-03-01)

Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
by: Woldesellassie M. Bezabhe, et al.
Published: (2022-10-01)

Assessment of novel oral anticoagulant use within a community teaching hospital
by: Sultan Alghadeer, et al.
Published: (2017-01-01)

The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
by: Brendan Wood, et al.
Published: (2017-08-01)

Utilization and prescribing patterns of direct oral anticoagulants
by: Whitworth MM, et al.
Published: (2017-03-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A TWO-YEAR COHORT STUDY
by: A. V. Zhilenko, et al.
Published: (2017-07-01)

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
by: S. R. Gilyarevsky
Published: (2022-07-01)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
by: Song AB, et al.
Published: (2019-06-01)

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?
by: Luca Masotti, et al.
Published: (2019-01-01)

Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study
by: Korayem GB, et al.
Published: (2023-01-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
by: Agnieszka Kapłon-Cieślicka, et al.
Published: (2022-05-01)

Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023-07-01)

Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy
by: Lorenzo Giovanni Mantovani, et al.
Published: (2013-09-01)

Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics
by: Luca Masotti, et al.
Published: (2013-12-01)

Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true
by: Yu. A. Bunin, et al.
Published: (2016-09-01)